Description

7-[(1,4,5,6-Tetrahydro-4-Methyl-6-Oxopyridazin)-3-Yl]-4H-1,4-Benzoxazin-3(2H)-One is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is valued for its role as a critical building block in the synthesis of novel active pharmaceutical ingredients (APIs). It is primarily sought by research institutions and manufacturers in the pharmaceutical and agrochemical industries for the development of new therapeutic and crop protection agents.

Application

• Pharmaceutical Intermediate: Key precursor in the research and synthesis of novel drug candidates, particularly in central nervous system (CNS) and anti-inflammatory therapeutic areas.
• Agrochemical Research: Used as a core scaffold for developing new-generation herbicides and pesticides with targeted action.
• Chemical Biology Probe: Serves as a specialized tool compound for studying enzyme inhibition and receptor binding mechanisms in biochemical research.
• Organic Synthesis Building Block: Employed in complex multi-step organic syntheses to construct fused heterocyclic systems of interest.
• Material Science Research: Investigated for potential use in creating novel organic electronic materials or ligands for catalytic systems.

Basic Information

Product Name	7-[(1,4,5,6-Tetrahydro-4-Methyl-6-Oxopyridazin)-3-Yl]-4H-1,4-Benzoxazin-3(2H)-One
CAS No.	112018-01-6
Molecular Formula	C₁₅H₁₄N₄O₃
Molecular Weight	298.30 g/mol
Synonyms	7-[(4-Methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)]-2,3-dihydro-4H-1,4-benzoxazin-3-one; 7-(4-Methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-2,3-dihydro-4H-benzo[b][1,4]oxazin-3-one; 112018-01-6; 3(2H)-Benzoxazinone, 7-[(1,4,5,6-tetrahydro-4-methyl-6-oxo-3-pyridazinyl)]-4H-; 7-(4-Methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-4H-benzo[b][1,4]oxazin-3(2H)-one
EINECS	Contact for details

Quality Control

Every batch of 7-[(1,4,5,6-Tetrahydro-4-Methyl-6-Oxopyridazin)-3-Yl]-4H-1,4-Benzoxazin-3(2H)-One is manufactured and tested under strict quality management systems. We provide comprehensive analytical data to ensure the material meets the high-purity standards required for pharmaceutical R&D and scale-up. A detailed Certificate of Analysis (COA) confirming identity, purity (typically ≥97% by HPLC), and impurity profile is available for each lot upon request.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). The compound may be light-sensitive and should be handled accordingly to maintain stability.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Conforms to reference
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 20 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.